The weekly litigation news digest is live. Subscribe now

IP Verse

Corticosteroid Compositions - EP2214679

The patent EP2214679 was granted to Meritage Pharma on Mar 27, 2019. The application was filed on Nov 12, 2008 under application number EP08850126A. The patent is currently recorded with a legal status of "Revoked".

EP2214679

MERITAGE PHARMA
Application Number
EP08850126A
Filing Date
Nov 12, 2008
Status
Revoked
Sep 24, 2021
Publication Date
Mar 27, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
AECHTERDec 27, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE
DR FALK PHARMADec 19, 2019LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6291445
DESCRIPTIONUS6686346
DESCRIPTIONUS6986904
DESCRIPTIONWO2008070129
INTERNATIONAL-SEARCH-REPORTUS2004023935
INTERNATIONAL-SEARCH-REPORTUS2006193783
INTERNATIONAL-SEARCH-REPORTUS2007111978
INTERNATIONAL-SEARCH-REPORTUS6899099
OPPOSITIONEP1310243
OPPOSITIONUS2007111978
OPPOSITIONUS6598603
OPPOSITIONWO2009064457
SEARCHUS2007111978
SEARCHUS6598603

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents